The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)186-192
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number1
DOIs
Publication statusPublished - 2010

Cite this

@article{ef8e2219f9da44bcaad56d3b16e53241,
title = "The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents",
author = "M. Boers",
year = "2010",
doi = "10.1136/ard.2009.115832",
language = "Undefined/Unknown",
volume = "69",
pages = "186--192",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents

AU - Boers, M.

PY - 2010

Y1 - 2010

U2 - 10.1136/ard.2009.115832

DO - 10.1136/ard.2009.115832

M3 - Article

VL - 69

SP - 186

EP - 192

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -